Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × ivosidenib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 8 Glioma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Cholangiocarcinoma 2 Xanthogranuloma, Juvenile 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Leukemia 1 IDH1-Mutated Malignancies 1 Histiocytic Sarcoma 1 Central Nervous System Neoplasms 1

Interventions

Rituximab 25 Cyclophosphamide 23 Lenalidomide 20 Prednisone 11 fludarabine 10 Vincristine 10 Doxorubicin 10 obinutuzumab 8 Bendamustine Hydrochloride 8 zanubrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 tazemetostat 6 fludarabine phosphate 6 Biopsy 6 R-CHOP protocol 4 ibrutinib 3 Therapeutics 3 Radiotherapy 3 Exercise 3 Cyclosporine 3 venetoclax 2 tislelizumab 2 tisagenlecleucel 2 pirtobrutinib 2 copanlisib 2 axicabtagene ciloleucel 2 Whole-Body Irradiation 2 Temozolomide 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡